Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Beauty Health (SKIN) Gains from Investment Securities (2020 - 2025)

Historic Gains from Investment Securities for Beauty Health (SKIN) over the last 6 years, with Q3 2025 value amounting to -$210000.0.

  • Beauty Health's Gains from Investment Securities rose 4976.08% to -$210000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$419000.0, marking a year-over-year increase of 9360.5%. This contributed to the annual value of -$3.1 million for FY2024, which is 7426.8% up from last year.
  • As of Q3 2025, Beauty Health's Gains from Investment Securities stood at -$210000.0, which was up 4976.08% from $210000.0 recorded in Q2 2025.
  • In the past 5 years, Beauty Health's Gains from Investment Securities registered a high of $199.3 million during Q3 2021, and its lowest value of -$52.1 million during Q1 2022.
  • Its 5-year average for Gains from Investment Securities is $10.2 million, with a median of -$383500.0 in 2024.
  • As far as peak fluctuations go, Beauty Health's Gains from Investment Securities tumbled by 21404.21% in 2022, and later surged by 11743.64% in 2023.
  • Beauty Health's Gains from Investment Securities (Quarter) stood at $6.0 million in 2021, then plummeted by 214.04% to -$6.8 million in 2022, then surged by 47.89% to -$3.6 million in 2023, then skyrocketed by 98.03% to -$70000.0 in 2024, then crashed by 200.0% to -$210000.0 in 2025.
  • Its Gains from Investment Securities stands at -$210000.0 for Q3 2025, versus $210000.0 for Q2 2025 and -$349000.0 for Q1 2025.